You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 24 No. 6, June 1971 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Virus Antibodies and Multiple Sclerosis

John L. Sever, PhD, MD; John F. Kurtzke, MD, FACP; Milton Alter, MD; George A. Schumacher, MD; Mary Ruth Gilkeson; Jonas H. Ellenberg, PhD; Jacob A. Brody, MD

Arch Neurol. 1971;24(6):489-494.


Abstract

Virus antibody levels were determined for multiple sclerosis patients and matched controls from three different locations. For rubeola, several different antigen preparations were used. Measles antibody titers were significantly elevated in multiple sclerosis patients in Washington, DC, increased in the patients in Minneapolis, and somewhat elevated in the patients in Vermont. In the Vermont series, the trend for high measles antibody levels only became apparent when sibling controls were excluded from the analysis. Antibody levels for respiratory syncytial virus, adenovirus, mumps, and varicella were also increased among multiple sclerosis patients in individual groups, but this was not consistent for all three groups.



Author Affiliations

Bethesda, Md; Washington, DC; Minneapolis; Burlington, Vt; Bethesda

From the Section on Infectious Diseases, Perinatal Research Branch (Dr. Sever and Miss Gilkeson), Section on Mathematical Statistics, Office of Biometry (Dr. Ellenberg), and Epidemiology Branch (Dr. Brody), National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Md; the Neurology Service (Dr. Kurtzke), Veterans Administration Hospital, Washington, DC; the Neurology Service (Dr. Alter), Veterans Administration Hospital, Minneapolis; and Division of Neurology (Dr. Schumacher), College of Medicine, University of Vermont, Burlington, Vt.


Footnotes

Accepted for publication Jan 2, 1971.

Reprint requests to National Institute of Neurological Diseases and Stroke, Perinatal Research Branch, 36/5D04, Bethesda, Md 20014 (Dr. Sever).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Epstein-Barr Virus Antibodies in Multiple Sclerosis
Sumaya et al.
Arch Neurol 1980;37:94-96.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.